Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.60 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29131378 | 0.84 | SLC22A6 (0.55) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL28052189 | 0.82 | MEN1 (0.66) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL670562 | 0.82 | PKM (0.55) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL11539489 | 0.81 | MEN1 (0.64) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL5702623 | 0.80 | HTR1A (0.56) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL6835992 | 0.80 | MEN1 (0.68) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL670290 | 0.80 | KDM4E (0.58) | KDM4EPOLBHDAC6GAA | |
| SCHEMBL30393910 | 0.78 | BLM (0.69) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| Vanillic Acid SCHEMBL20481367 | 0.78 | HTT (0.71) | KMT2ASLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL15004192 | 0.78 | MEN1 (0.64) | KMT2ASLC22A6SLC22A8MEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102872064-A | Method for extracting alpha-glucosidase activity inhibitor from lycium barbarum seeds and residues after extraction of lycium barbarum oil from lycium barbarum seeds and application thereof | NINGXIA INST FOR DRUG CONTROL | 2013-01-16 | — | — | CN | claimed |
| US-11826396-B2 | Nutriprotective diet | FEDERATION DES PRODUCTEURS ACERICOLES DU QUEBEC (CA) | 2023-11-28 | — | — | US | disclosed |
| US-20190070245-A1 | NUTRIPROTECTIVE DIET | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2019-03-07 | — | — | US | disclosed |
| CN-102872064-B | Seed of Fructus Lycii and extract method extracting alpha-glucosidase activity inhibitor and uses thereof in the residue after Lycium-seed-oil | NINGXIA HUI AUTONOMOUS PREFECTURE INSTITUTE FOR DRUG CONTROL (CN) | 2015-08-19 | — | — | CN | disclosed |
| US-20150140143-A1 | NUTRIPROTECTIVE DIET | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2015-05-21 | — | — | US | disclosed |
| US-20150140143-A1 | NUTRIPROTECTIVE DIET | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2015-05-21 | — | — | US | disclosed |
| US-20130267474-A1 | NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF | UNIVERSITY OF RHODE ISLAND (US) | 2013-10-10 | — | — | US | disclosed |
| US-20130203688-A1 | SUGAR PLANT DERIVED BY-PRODUCTS AND METHODS OF PRODUCTION THEREOF | FÉDÉRATION DES PRODUCTEURS ACÉRI-COLES DU QUÉBEC (CA) | 2013-08-08 | — | — | US | disclosed |
| WO-2013033828-A1 | NUTRIPROTECTIVE DIET | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2013-03-14 | — | — | WO | disclosed |
| CN-102872064-A | Method for extracting alpha-glucosidase activity inhibitor from lycium barbarum seeds and residues after extraction of lycium barbarum oil from lycium barbarum seeds and application thereof | NINGXIA INST FOR DRUG CONTROL | 2013-01-16 | — | — | CN | disclosed |
| WO-2012055010-A1 | MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012021983-A1 | SUGAR PLANT DERIVED BY-PRODUCTS AND METHODS OF PRODUCTION THEREOF | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2012-02-23 | — | — | WO | disclosed |
| WO-2012021981-A1 | NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2012-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11826396-B2 | Nutriprotective diet | NEFM, NNMT, SORD | KMT2A 3107/4885SLC22A6 60/4885SLC22A8 428/4885 |
| US-20130267474-A1 | NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF | BPHL, OAT, PSAT1 | KMT2A 4123/4885SLC22A6 2926/4885SLC22A8 2375/4885 |
| US-20130203688-A1 | SUGAR PLANT DERIVED BY-PRODUCTS AND METHODS OF PRODUCTION THEREOF | SORD, TREH, CUTA | KMT2A 2406/4885SLC22A6 142/4885SLC22A8 340/4885 |
| US-20190070245-A1 | NUTRIPROTECTIVE DIET | NEFM, NNMT, SORD | KMT2A 3107/4885SLC22A6 60/4885SLC22A8 428/4885 |
| US-20150140143-A1 | NUTRIPROTECTIVE DIET | NEFM, NNMT, SORD | KMT2A 3298/4885SLC22A6 68/4885SLC22A8 452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.